Differences in the Presentation and Progression of Parkinson's Disease by Sex

Archive ouverte

Iwaki, Hirotaka | Blauwendraat, Cornelis | Leonard, Hampton | Makarious, Mary | Kim, Jonggeol | Liu, Ganqiang | Maple-Grødem, Jodi | Corvol, Jean‐christophe | Pihlstrøm, Lasse | van Nimwegen, Marlies | Smolensky, Luba | Amondikar, Ninad | Hutten, Samantha | Frasier, Mark | Nguyen, Khanh‐dung | Rick, Jacqueline | Eberly, Shirley | Faghri, Faraz | Auinger, Peggy | Scott, Kirsten | Wijeyekoon, Ruwani | van Deerlin, Vivianna | Hernandez, Dena | Gibbs, Raphael | Day-Williams, Aaron | Brice, Alexis | Alves, Guido | Noyce, Alastair | Tysnes, Ole‐bjørn | Evans, Jonathan | Breen, David | Estrada, Karol | Wegel, Claire | Danjou, Fabrice | Simon, David | Andreassen, Ole | Ravina, Bernard | Toft, Mathias | Heutink, Peter | Bloem, Bastiaan | Weintraub, Daniel | Barker, Roger | Williams-Gray, Caroline | van de Warrenburg, Bart | van Hilten, Jacobus | Scherzer, Clemens | Singleton, Andrew | Nalls, Mike

Edité par CCSD ; Wiley -

International audience. ABSTRACT Background Previous studies reported various symptoms of Parkinson's disease (PD) associated with sex. Some were conflicting or confirmed in only one study. Objectives We examined sex associations to PD phenotypes cross‐sectionally and longitudinally in large‐scale data. Methods We tested 40 clinical phenotypes, using longitudinal, clinic‐based patient cohorts, consisting of 5946 patients, with a median follow‐up of 3.1 years. For continuous outcomes, we used linear regressions at baseline to test sex‐associated differences in presentation, and linear mixed‐effects models to test sex‐associated differences in progression. For binomial outcomes, we used logistic regression models at baseline and Cox regression models for survival analyses. We adjusted for age, disease duration, and medication use. In the secondary analyses, data from 17 719 PD patients and 7588 non‐PD participants from an online‐only, self‐assessment PD cohort were cross‐sectionally evaluated to determine whether the sex‐associated differences identified in the primary analyses were consistent and unique to PD. Results Female PD patients had a higher risk of developing dyskinesia early during the follow‐up period, with a slower progression in activities of daily living difficulties, and a lower risk of developing cognitive impairments compared with male patients. The findings in the longitudinal, clinic‐based cohorts were mostly consistent with the results of the online‐only cohort. Conclusions We observed sex‐associated contributions to PD heterogeneity. These results highlight the necessity of future research to determine the underlying mechanisms and importance of personalized clinical management. © 2020 International Parkinson and Movement Disorder Society

Consulter en ligne

Suggestions

Du même auteur

Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts

Archive ouverte | Iwaki, Hirotaka | CCSD

International audience. Abstract Background Several reports have identified different patterns of Parkinson's disease progression in individuals carrying missense variants in GBA or LRRK2 genes. The overall contribu...

Genetic risk of Parkinson disease and progression:

Archive ouverte | Iwaki, Hirotaka | CCSD

International audience

Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

Archive ouverte | Nalls, Mike | CCSD

International audience. Background: Genome-wide association studies (GWAS) in Parkinson's disease have increased the scope of biological knowledge about the disease over the past decade. We aimed to use the largest ...

Chargement des enrichissements...